India to Philippines: Doxorubicin Export Trade Route
India has recorded 167 verified shipments of Doxorubicin exported to Philippines, representing a combined trade value of $1.1M USD. This corridor is served by 22 active Indian exporters, with an average shipment value of $6.7K USD. The leading Indian exporter is VEXXA LIFESCIENCES PRIVATE LIMITED, which accounts for 15% of total export value with 39 shipments worth $162.9K USD. On the buying side, VE PHARMA INC is the largest importer in Philippines with $301.9K USD in purchases. The top 3 suppliers — VEXXA LIFESCIENCES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT. LTD., VEXXA LIFESCIENCES PVT. LTD. — together control 44% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Doxorubicin corridor is one of India's established pharmaceutical export routes, with 167 shipments documented worth a combined $1.1M USD. The route is dominated by VEXXA LIFESCIENCES PRIVATE LIMITED, which alone accounts for roughly 15% of all export value, reflecting the consolidated nature of India's doxorubicin manufacturing sector.
Across 22 active suppliers, the average shipment value stands at $6.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with doxorubicin's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 17.4%, placing it at rank #7 among India's top doxorubicin export destinations globally.
On the import side, key buyers of Indian doxorubicin in Philippines include VE PHARMA INC, Ve Pharma Inc. , AMBICA INTERNATIONAL CORPORATION and 28 others. VE PHARMA INC is the single largest importer with 65 shipments valued at $301.9K USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ1
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#7
- Annual growth+17.4%
- Demand growth+16.8%
- Regulatory ease74/100
Top 10 Indian Doxorubicin Exporters to Philippines
Showing top 10 of 22 Indian suppliers exporting Doxorubicin to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VEXXA LIFESCIENCES PRIVATE LIMITED Avg $4.2K per shipment | 39 | $162.9K | 14.6% |
| 2 | VEXXA LIFESCIENCES PVT. LTD. Avg $4.8K per shipment | 34 | $162.9K | 14.6% |
| 3 | VEXXA LIFESCIENCES PVT. LTD. Avg $7.1K per shipment | 23 | $162.6K | 14.5% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $56.5K per shipment | 2 | $113.0K | 10.1% |
| 5 | ADMAC LIFESCIENCES Avg $4.5K per shipment | 18 | $80.3K | 7.2% |
| 6 | GETWELL PHARMA INDIA PRIVATE LIMITED Avg $12.1K per shipment | 6 | $72.5K | 6.5% |
| 7 | KHANDELWAL LABORATORIES PRIVATE LIMITED Avg $5.9K per shipment | 12 | $71.0K | 6.3% |
| 8 | NATCO PHARMA LIMITED Avg $20.6K per shipment | 3 | $61.9K | 5.5% |
| 9 | GETWELL PHARMACEUTICALS Avg $6.1K per shipment | 8 | $48.9K | 4.4% |
| 10 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $41.1K per shipment | 1 | $41.1K | 3.7% |
This table shows the top 10 of 22 Indian companies exporting doxorubicin to Philippines, ranked by total trade value. The listed exporters are: VEXXA LIFESCIENCES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT. LTD., VEXXA LIFESCIENCES PVT. LTD. , SUN PHARMACEUTICAL INDUSTRIES LIMITED , ADMAC LIFESCIENCES, GETWELL PHARMA INDIA PRIVATE LIMITED, KHANDELWAL LABORATORIES PRIVATE LIMITED, NATCO PHARMA LIMITED, GETWELL PHARMACEUTICALS, SUN PHARMACEUTICAL INDUSTRIES LIMITED. VEXXA LIFESCIENCES PRIVATE LIMITED is the dominant supplier with 39 shipments worth $162.9K USD, giving it a 15% market share. The top 3 suppliers together account for 44% of the total trade value on this route.
Showing top 10 of 22 total Indian exporters on the India to Philippines Doxorubicin export route.
Top 10 Doxorubicin Importers in Philippines
Showing top 10 of 31 known buyers in Philippines receiving Doxorubicin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian doxorubicin in Philippines include VE PHARMA INC, Ve Pharma Inc. , AMBICA INTERNATIONAL CORPORATION, SUN PHARMA PHILIPPINES INC. , ASIA UNITED BANK CORPORATION, among 31 total buyers. The largest importer is VE PHARMA INC, accounting for $301.9K USD across 65 shipments — representing 27% of all doxorubicin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VE PHARMA INC | 65 | $301.9K | 27.0% |
| 2 | Ve Pharma Inc. | 22 | $151.3K | 13.5% |
| 3 | AMBICA INTERNATIONAL CORPORATION | 14 | $121.4K | 10.9% |
| 4 | SUN PHARMA PHILIPPINES INC. | 2 | $113.0K | 10.1% |
| 5 | ASIA UNITED BANK CORPORATION | 3 | $63.4K | 5.7% |
| 6 | PHARMASTAR INTL TRADING CORP | 9 | $49.6K | 4.4% |
| 7 | NATCO LIFESCIENCES PHILIPPINES INC | 2 | $47.8K | 4.3% |
| 8 | SUN PHARMA PHILIPPINES INC. | 1 | $41.1K | 3.7% |
| 9 | NATCO LIFESCIENCES PHILIPPINES INC | 2 | $34.2K | 3.1% |
| 10 | AMBICA INTERNATIONAL CORPORATION | 4 | $27.2K | 2.4% |
Showing top 10 of 31 Doxorubicin importers in Philippines on this route.
Top 10 Doxorubicin Formulations Imported by Philippines
Showing top 10 of 92 product formulations shipped on the India to Philippines Doxorubicin route, ranked by trade value
Philippines imports a wide range of doxorubicin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CHEMODOX(DOXORUBICIN HYDROCHLORIDE LIPSO — accounts for $113.0K USD across 2 shipments. There are 92 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CHEMODOX(DOXORUBICIN HYDROCHLORIDE LIPSO | 2 | $113.0K | 10.1% |
| 2 | Doxvex 50 (DOXORUBICIN HYDROCHLORIDE POW | 12 | $85.1K | 7.6% |
| 3 | DACTORUBIN DOXORUBICIN AS HYDROCHLORI | 9 | $63.4K | 5.7% |
| 4 | CHEMODOX INJECTION (DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION 2MG/ML, 10ML VIAL) [1042 PACK X 1X1] | 1 | $41.1K | 3.7% |
| 5 | DOXORUBICIN HYDROCHLORIDE LIPOSOME INJEC | 2 | $34.2K | 3.1% |
| 6 | DOXVEX 50 DOXORUBICINHYDROCHLORIDEPOWDERFORINJECTIONUSP BATCH NO DXLJ23B21- A MANUFACTURING DT OCT-2023 EXP DT SEP-2025 | 4 | $27.6K | 2.5% |
| 7 | Doxvex 50 INJ DOXORUBICIN HYDROCHLORIDE | 5 | $25.7K | 2.3% |
| 8 | INJECTION DOXORUBICIN HYDROCHLORIDE LIPOSOME 2MG/ML20MG/10MLNATDOX-LP FDA REGISTRATION NUMBER: DRP-9235 | 1 | $25.7K | 2.3% |
| 9 | DOXVEX 50 ( DOXORUBICIN HYDROCHLORIDE PO | 4 | $25.4K | 2.3% |
| 10 | INJECTION DOXORUBICIN HYDROCHLORIDE LIPOSOME 2MG/ML50MG/25MLNATDOX-LP FDA REGISTRATION NUMBER: DRP-9234 | 1 | $22.1K | 2.0% |
Showing top 10 of 92 Doxorubicin formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 73%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 62 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's doxorubicin exports to Philippines are driven primarily by a handful of large-scale manufacturers. VEXXA LIFESCIENCES PRIVATE LIMITED with 39 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 22 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — VEXXA LIFESCIENCES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT. LTD., VEXXA LIFESCIENCES PVT. LTD. — together account for 44% of total trade value on this route. The average shipment value of $6.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as doxvex 50 (doxorubicin hydrochloride pow and dactorubin doxorubicin as hydrochlori, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, VE PHARMA INC is the largest importer with 65 shipments worth $301.9K USD — representing 27% of all doxorubicin imports from India on this route. A total of 31 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.1M
- Avg. Shipment
- $6.7K
- Suppliers
- 22
- Buyers
- 31
- Transit (Sea)
- ~18 days
- Annual Growth
- +17.4%
Related Analysis
Other Doxorubicin Routes
Unlock the Full India to Philippines Doxorubicin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 167 shipments on this route.
Frequently Asked Questions — India to Philippines Doxorubicin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Doxorubicin to Philippines?
The leading Indian exporters of Doxorubicin to Philippines are VEXXA LIFESCIENCES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT. LTD., VEXXA LIFESCIENCES PVT. LTD. . VEXXA LIFESCIENCES PRIVATE LIMITED holds the largest market share at approximately 15% of total trade value on this route.
Q What is the total value of Doxorubicin exports from India to Philippines?
India exports Doxorubicin to Philippines worth approximately $1.1M USD across 167 recorded shipments. The average value per shipment is $6.7K USD.
Q Which ports does India use to ship Doxorubicin to Philippines?
The most active port of origin is DELHI AIR with 62 shipments. Indian exporters primarily use sea freight for this route, with 73% of shipments going by sea and 21% by air.
Q How long does shipping take from India to Philippines for Doxorubicin?
The average transit time for Doxorubicin shipments from India to Philippines is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Philippines Doxorubicin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 17.4% with demand growth tracking at 16.8%. The route is ranked #7 among India's top Doxorubicin export destinations globally.
Q How many suppliers are active on the India to Philippines Doxorubicin route?
There are currently 22 active Indian suppliers exporting Doxorubicin to Philippines. The market is moderately concentrated with VEXXA LIFESCIENCES PRIVATE LIMITED accounting for 15% of total shipment value.
Q Who are the main importers of Doxorubicin from India in Philippines?
The leading importers of Indian Doxorubicin in Philippines include VE PHARMA INC, Ve Pharma Inc. , AMBICA INTERNATIONAL CORPORATION, SUN PHARMA PHILIPPINES INC. , ASIA UNITED BANK CORPORATION. VE PHARMA INC is the largest buyer with 65 shipments worth $301.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Doxorubicin.
- 2.Supplier/Buyer Matching: 22 Indian exporters and 31 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 167 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
167 Verified Shipments
22 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists